These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26640728)

  • 1. Aggressive FLC Escape in a Patient with IgD Myeloma.
    Farges C; Roussel M; Huynh A; Blancher A; Puissant-Lubrano B
    Case Rep Hematol; 2015; 2015():694730. PubMed ID: 26640728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome.
    Brioli A; Giles H; Pawlyn C; Campbell JP; Kaiser MF; Melchor L; Jackson GH; Gregory WM; Owen RG; Child JA; Davies FE; Cavo M; Drayson MT; Morgan GJ
    Blood; 2014 May; 123(22):3414-9. PubMed ID: 24733348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
    Caldini A; Nozzoli C; Terreni A; Staderini M; Berardi M; Biagioli T; Brogi M; Bosi A
    Clin Chem Lab Med; 2016 Jun; 54(6):991-5. PubMed ID: 26581069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
    BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
    Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
    Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report.
    De Santis E; Masi S; Cordone I; Pisani F; Zuppi C; Mattei F; Conti L; Cigliana G
    Oncol Lett; 2016 Sep; 12(3):1884-1888. PubMed ID: 27588135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum free light chains for monitoring multiple myeloma.
    Mead GP; Carr-Smith HD; Drayson MT; Morgan GJ; Child JA; Bradwell AR
    Br J Haematol; 2004 Aug; 126(3):348-54. PubMed ID: 15257706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving use of serum free light chain assays in haematology.
    Pratt G
    Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome.
    Avivi I; Cohen YC; Joffe E; Benyamini N; Held-Kuznetsov V; Trestman S; Terpos E; Dimopoulos MA; Kastritis E
    Hematol Oncol; 2017 Dec; 35(4):734-740. PubMed ID: 27641057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Light chain escape followed by leukemic transformation in a patient with IgD myeloma].
    Hatsuse M; Fuchida S; Okano A; Murakami S; Shimazaki C
    Rinsho Ketsueki; 2015 Jan; 56(1):48-50. PubMed ID: 25745970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
    Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BG;
    Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
    Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
    Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma.
    Kraj M; Kruk B; Lech-Marańda E; Warzocha K; Prochorec-Sobieszek M
    Leuk Lymphoma; 2015; 56(12):3348-56. PubMed ID: 25860239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties.
    Kaplan B; Ramirez-Alvarado M; Dispenzieri A; Zeldenrust SR; Leung N; Livneh A; Gallo G
    Clin Chem Lab Med; 2008; 46(3):335-41. PubMed ID: 18254719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System].
    Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M
    Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].
    Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B
    Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light Chain Escape in 3 Cases: Evidence of Intraclonal Heterogeneity in Multiple Myeloma from a Single Institution in Poland.
    Kraj M; Kruk B; Endean K; Warzocha K; Budziszewska K; Dąbrowska M
    Case Rep Hematol; 2015; 2015():809840. PubMed ID: 26881153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.